Editorial. Methotrexate for Wegener's granulomatosis: What is the evidence?

Ulrich Specks

doi:10.1002/art.21146

Editorial. Methotrexate for Wegener's granulomatosis: What is the evidence?

Ulrich Specks

Pulmonary and Critical Care Medicine

Research output: Contribution to journal › Editorial › peer-review

22 Scopus citations

Original language	English (US)
Pages (from-to)	2237-2242
Number of pages	6
Journal	Arthritis and rheumatism
Volume	52
Issue number	8
DOIs	https://doi.org/10.1002/art.21146
State	Published - Aug 2005

ASJC Scopus subject areas

Immunology and Allergy
Rheumatology
Immunology
Pharmacology (medical)

Access to Document

10.1002/art.21146

Cite this

@article{4863d4fea5714788a8b5880c11f65f61,

title = "Editorial. Methotrexate for Wegener's granulomatosis: What is the evidence?",

author = "Ulrich Specks",

year = "2005",

month = aug,

doi = "10.1002/art.21146",

language = "English (US)",

volume = "52",

pages = "2237--2242",

journal = "Arthritis and rheumatism",

issn = "0004-3591",

publisher = "John Wiley and Sons Ltd",

number = "8",

}

TY - JOUR

T1 - Editorial. Methotrexate for Wegener's granulomatosis

T2 - What is the evidence?

AU - Specks, Ulrich

PY - 2005/8

Y1 - 2005/8

UR - http://www.scopus.com/inward/record.url?scp=23644441524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23644441524&partnerID=8YFLogxK

U2 - 10.1002/art.21146

DO - 10.1002/art.21146

M3 - Editorial

C2 - 16052540

AN - SCOPUS:23644441524

SN - 0004-3591

VL - 52

SP - 2237

EP - 2242

JO - Arthritis and rheumatism

JF - Arthritis and rheumatism

IS - 8

ER -

Editorial. Methotrexate for Wegener's granulomatosis: What is the evidence?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this